Xiaoya Hou Selected Research

9-(2,3-dihydroxypropyl)adenine

12/2019

Novel mitochondrial targeting charge-reversal polysaccharide hybrid shell/core nanoparticles for prolonged systemic circulation and antitumor drug delivery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoya Hou Research Topics

Disease

5	Neoplasms (Cancer) 01/2021 - 12/2019
1	Rheumatoid Arthritis 12/2022
1	Liver Neoplasms (Liver Cancer) 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Atherosclerosis 03/2020
1	Breast Neoplasms (Breast Cancer) 12/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2019

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 01/2021 - 12/2019
3	Hyaluronic Acid (Hyaluronan)IBA 01/2021 - 12/2019
3	CurcuminIBA 01/2021 - 12/2019
2	MicellesIBA 12/2019 - 12/2019
1	EnzymesIBA 12/2022
1	Dextran SulfateIBA 12/2022
1	Scavenger Receptors (Scavenger Receptor)IBA 12/2022
1	celastrolIBA 12/2022
1	Polysaccharides (Glycans)IBA 01/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2019
1	baicalinIBA 12/2019
1	icariinIBA 12/2019
1	Biotin (Vitamin H)FDA Link 12/2019
1	BoratesIBA 12/2019
1	EstersIBA 12/2019
1	9-(2,3-dihydroxypropyl)adenineIBA 12/2019
1	PolymersIBA 12/2019

Therapy/Procedure

5	Therapeutics 01/2021 - 12/2019
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021